Financials
Financial year 2024
ADJUVANS from Ieper, company number BE0668392653, closed financial year 2024 with a result of € 73,914 after tax. For that financial year ADJUVANS recorded a gross margin of € 103,136 and equity of € 973,148. Compared with financial year 2023, the result moved from € 80,237 to € 73,914. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2025.
€ 973,148
▲ 8% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 73,914
▼ 8% vs 2023
Profit after tax over the fiscal year.
€ 62,936
▼ 20% vs 2023
Cash and bank balances on the last day of the fiscal year.
€ 1,666 paid out
2 % of the profit went to the shareholders, the rest stayed in the company.
Debts at end 2024
€ 520,787
▼ 12% vs 2023
€ 143,932 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 4,869
▼ 11% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 4,338
▲ 11% vs 2023
Taxes, VAT and social contributions still to pay.
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 122,358 | € 122,062 | € 110,218 | € 103,136 | ▼ 6% |
| Profit after taxes | € 286,461 | € 88,613 | € 80,237 | € 73,914 | ▼ 8% |
| Equity | € 758,716 | € 822,329 | € 900,900 | € 973,148 | ▲ 8% |
| Total debts | € 753,419 | € 707,074 | € 611,618 | € 541,389 | ▼ 11% |
| Cash | € 97,230 | € 114,425 | € 78,431 | € 62,936 | ▼ 20% |
| Retained profit | € 608,716 | € 672,329 | € 750,900 | € 823,148 | ▲ 10% |
| Dividend | € 0 | € 25,000 | € 1,666 | € 1,666 | |
| Bank debt | € 729,677 | € 660,955 | € 591,322 | € 520,787 | ▼ 12% |
| Balance sheet total | € 1,512,135 | € 1,529,403 | € 1,512,518 | € 1,514,537 |
Key figures of ADJUVANS, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to ADJUVANS?
What happened at ADJUVANS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 73,914 (▼ 8% vs 2023). filed late Source: NBB ↗
- New establishment in Ieper. KBO
- Start of the company according to the CBE. KBO
In short
From € 286,461 profit in 2021 to € 73,914 profit in 2024.
Paid € 87,372 in corporate taxes since 2021.
Best year ever: 2021, with € 286,461 profit.
Paid out € 28,332 in dividends to the owners in total.
Management
Behind ADJUVANS is Julie Schouteten. It owns 99.5% of Pharmacie Schouteten itself.
Directors
According to the 2024 annual accounts
Julie Schouteten
Director
Establishments
Establishment units
Physical locations of this company
Adriaansensweg 29
8900 Ieper
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0668.392.653
- VAT number
- BE 0668.392.653
- Registered office
- Adriaansensweg 29, 8900 Ieper
- Names & denominations
- ADJUVANS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 December 2016
- Peppol
- Active · Active since 18 Oct 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Activiteiten van holdings
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
Holdings
Adviesbureaus op het gebied van public relations en communicatie